Key Takeaways
- A transition year, not a growth year: Full-year revenue fell to ₹3,228 cr from ₹3,466 cr, with Q4 down ~20% YoY, as domestic ethanol execution cycles stretched by 12 months and export order timing slipped.
- Margin improved sequentially despite the top-line drop: Q4 margin rose ~2.3% over Q3 after adjusting for material costs, and management’s stated first target is sustainable double-digit EBITDA.
- The order book is shifting from plain ethanol to a multi-engine story: CBG, services, international projects, co-products, and the new GenX facility are all expected to contribute to order inflow as FY26 progresses, though management declined to give a number.
- GenX is ready but revenue will be back-loaded: The Mangalore facility is fully operational with three long-term framework agreements signed, but meaningful revenue will only start in H2 FY26, with break-even estimated at ₹400–450 cr of revenue.
- What to watch next quarter: Whether the promised order book build-up in engineering and CBG materializes in H1, the pace of GenX order finalization, and any movement on the 45Z draft notification for US SAF.
Revenue Decline: What Broke in FY25
- Domestic ethanol execution stretched: Funding agencies tightened approval processes, extending average execution cycles from 9–12 months to 12–15 months; Praj’s strict revenue recognition policy means it only books revenue when the client is ready, so the existing ₹3,300 cr bioenergy order book will now spill into FY26.
- Export order timing mismatch: International jobs started about six months late, pushing invoicing that would normally have landed in Q4 out of the fiscal year; larger engineering orders carry delivery cycles of 18–24 months.
- Engineering intake hit by capacity, not demand: Full-year engineering order intake fell ~17% YoY because the Kandla facility was fully booked for 18 months and the GenX facility was not yet ready, forcing Praj to reject orders.
- Bioenergy down 15%, engineering down 30% in Q4: The combined effect of elongated domestic cycles, late-starting export jobs, and capacity constraints drove the sharp Q4 decline.
Shishir Joshipura: "Praj business is a string made up of pearls represented by several business units."
The Multi-Engine Order Book Thesis
- CBG is moving from promise to orders: A 36 TPD single-location CBG project (one of India’s largest) is in the current quarter order book; a term sheet with BPCL covers 10 CBG projects under a JV; mandatory 5% blending from January next year provides a regulatory driver.
- Services order book doubled YoY: Traction is building for biogenic CO2 capture, fermentation process management, and O&M services, with rapid growth expected going forward.
- Internationalization accelerating: Stated strategy is to reach a 50-50 domestic-international mix even as sales grow 3x; local resources added in the Americas; engineering orders already underway for two projects in Brazil/Paraguay/Argentina that will later switch to equipment ordering.
- Co-products improving project viability: Technologies for distillers corn oil, rice protein, and high-protein DDGS are gaining traction from existing ethanol producers; rice protein is now ready to commercialize.
- Bioplastics JV signed with a global leader: Domestically developed technology expected to be very cost-competitive; a demo plant is ready for customer visits and joint pitching for orders has begun, though no timeline for first order booking is given.
- Bio-bitumen adds value to CBG: A National Highway stretch using Praj’s bio-bitumen was inaugurated near Nagpur; the product is a co-product from CBG waste stream processing and is under specification with CRRI.
Shishir Joshipura: "We have stated that we want to move to an eventual situation of 50-50 between domestic and international, even as we grow our sales 3x."
GenX: The Back-Half Story
- Facility is now fully ready: The Mangalore facility commenced operations in March 2024; eight key customers have audited and approved it; three have signed long-term (8-year) framework agreements setting guidelines for order placement.
- Revenue will be lumpy and back-loaded: Initial engineering components will come through first, then equipment and modularization work; meaningful revenue is expected only from H2 (Q3 onwards).
- Break-even estimated at ₹400–450 cr of revenue: Per an analyst’s math, confirmed by management as more or less correct; once orders execute, all fixed costs will be absorbed and the expense will not impact consolidated PBT.
- Scale-up costs of ~₹76 cr hit FY25 P&L: These costs will persist until revenue ramps; depreciation also increased from ₹44 cr to ₹86 cr due to capitalization of lease assets including the GenX facility.
- Orders are in finalization stage: Management describes them as in “handshake stage” but declined to disclose numbers before orders are finalized.
Ethanol Beyond EBP 20: The Domestic Demand Bridge
- EBP 20 achieved ahead of schedule: This marks a transition point; plain-vanilla greenfield ethanol projects are no longer the only option.
- Multiple demand levers identified: Flex-fuel vehicles (100% ethanol), diesel blending (testing in final stage), sustainable aviation fuel, co-product development, debottlenecking, and low-carbon intensity ethanol solutions all sit in the pipeline, though none carry firm timelines.
- EBP 25 or 30 under government discussion: No timeline given; will depend on regional feedstock availability and government push for starchy feedstocks.
- 45Z draft notification is the US catalyst: Likely enacted by October 2025; expected to create a significant pipeline for low-carbon ethanol opportunity in America, though management did not quantify expected order wins for FY26 or FY27.
Shishir Joshipura: "Just plain vanilla Greenfield projects are not the only option. There will be other Brownfield expansions, debottlenecking, all the other co-product development, etc. that I mentioned."
CBG: Regulatory Tailwinds, Industry Still Evolving
- Pricing mechanism now linked to 80% of CNG prices: This addresses a key industry concern around project viability.
- OMC and PSU participation improving off-take: OMC involvement directly addresses the off-take issue that has plagued the industry; CBG networks are being built across cities.
- Mandatory blending obligation from January next year: A 5% blend requirement in the grid becomes a regulatory driver.
- Solid and liquid fertilizer notified: CBG companies can now legally sell these products in the market, adding a revenue stream.
- Praj demonstrating execution capability: Commissioned a CBG plant with DCM in a record 60 days from start to final output at guaranteed level; building a very large single-location repeat contract for an existing customer.
Shishir Joshipura: "No other company can come anywhere near this record."
Margins, Provisions & Balance Sheet
- Margin improved sequentially in Q4: ~2.3% improvement over Q3 after considering cost of material and direct expenses; management’s first target is sustainable double-digit EBITDA.
- Services and internationalization are the margin levers: Higher-margin components are expected to be margin-accretive going forward.
- Bad debt provision of ₹25 cr is a policy change, not write-offs: No actual write-offs occurred; the company made its provisioning policy more aggressive as a precaution.
- Depreciation doubled YoY: Increase from ₹44 cr to ₹86 cr driven by capitalization of lease assets, especially the GenX facility; lease rentals are staggered from a cash flow perspective but the asset is capitalized upfront.
- Working capital question went unanswered: An analyst flagged that contracts work-in-progress rose from ₹700 cr to ₹1,000 cr; management did not address the question on the call.
Sachin Raole: "We always mention that our first target is to reach on a sustainable basis to a double-digit EBITDA margin. That is what we are trying to do right now."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Bioenergy order book execution | Existing ₹3,300 cr order book to be executed | 12–15 months |
| GenX meaningful revenue | Revenue ramp begins; break-even at ₹400–450 cr | H2 FY26 (Q3 onwards) |
| Engineering order book build-up | Order booking contribution begins; first two quarters will see build-up | FY26, starting H1 |
| CBG mandatory blending | 5% blend required in the grid | January 2026 |
| US 45Z enactment | Draft notification issued; expected to create low-carbon ethanol pipeline | Likely by October 2025 |
| International/domestic mix | Move to eventual 50-50 mix | As sales grow 3x; international to grow faster |
| Margin target | Reach sustainable double-digit EBITDA | No date given |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Consolidated income from operations | ₹800 cr, vs ₹1,000 cr in Q4 FY24 |
| PBT | ₹58.25 cr, vs ₹100 cr in Q4 FY24 |
| PAT | ₹39.82 cr, vs ₹91.94 cr in Q4 FY24 |
| Margin improvement over Q3 FY25 | ~2.3%, after considering cost of material and direct expenses |
| Full-year FY25 income from operations | ₹3,228 cr, vs ₹3,466.28 cr in FY24 |
| Full-year FY25 PBT | ₹270.3 cr, vs ₹377.4 cr in FY24 |
| Full-year FY25 PAT | ₹218.9 cr, vs ₹283.3 cr in FY24 |
| Export revenue share | 24% of total revenue in FY25, vs 18% in FY24 |
| Order intake | ₹1,032 cr, 61% domestic, 70% bioenergy, 21% engineering, 9% PHS |
| Order backlog | ₹4,293 cr as of March 2025, 63% domestic, 77% bioenergy, 18% engineering, 5% PHS |
| Cash in hand | ₹600 cr as of 31 March 2025 |
| Proposed final dividend | ₹6 per equity share, 300% of face value of ₹2, for FY25 |
| Praj GenX scale-up expenditure impact on consolidated PBT | ₹76 cr in FY25, with no corresponding revenue |
| CBG order signed | 36 TPD capacity, one of the largest single-location facilities in India |
| Services order book growth | ~2x in FY25 vs FY24 |